ArticleLeukemia2019

SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints.

Yunzhu Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.